Anti-β2-glycoprotein I paratopes and β2-glycoprotein I epitopes characterization using random peptide libraries

Autoimmunity

Volumn 47, Issue 7, 2014, Pages 438-444

  Žager, Urška ^a   Kveder, Tanja ^a   Čučnik, Saša ^a   Božič, Borut ^a,b   Lunder, Mojca ^b  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Antibody antigen interaction; Antiphospholipid syndrome; Epitope mimetics; Paratope mimetics; Phage display

Indexed keywords

BETA2 GLYCOPROTEIN 1; BETA2 GLYCOPROTEIN 1 ANTIBODY; EPITOPE; AUTOANTIBODY; PEPTIDE LIBRARY; PHOSPHOLIPID ANTIBODY;

AMINO ACID COMPOSITION; ANTIBODY COMBINING SITE; ANTIGEN STRUCTURE; ARTICLE; CONTROLLED STUDY; HUMAN; HYDROGEN BOND; MALE; PEPTIDE LIBRARY; PHAGE DISPLAY; PROTEIN CONFORMATION; ANTIBODY AFFINITY; ANTIPHOSPHOLIPID SYNDROME; IMMUNOLOGY;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIBODY AFFINITY; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; BINDING SITES, ANTIBODY; EPITOPES; HUMANS; MALE; PEPTIDE LIBRARY;

EID: 84912028344     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2014.914176     Document Type: Article

References (30)

1. Dani, M. 2001. Peptide display libraries: design and construction. J. Recept. Signal. Transduct. Res. 21: 469-488
2. Bottger, V., and A. Bottger. 2009. Epitope mapping using phage display peptide libraries. Methods Mol. Biol. 524: 181-201
3. Dani, M. 2001. Biological libraries. J. Recept. Signal. Transduct. Res. 21: 447-468
4. Atsumi, T., O. Amengual, S. Yasuda, et al. 2005. Research around beta 2-glycoprotein I: a major target for antiphospholipid antibodies. Autoimmunity. 38: 377-381
5. Tincani, A., G. Balestrieri, E. Danieli, et al. 2003. Pregnancy complications of the antiphospholipid syndrome. Autoimmunity. 36: 27-32
6. Blank, M., D. Faden, A. Tincani, et al. 1994. Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice. J. Autoimmun. 7: 441-455
7. Danowski, A., T. S. Kickler, and M. Petri. 2006. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus. J. Rheumatol. 33: 1775-1779
8. Tincani, A., C. Casu, S. Cartella, et al. 2010. Antiphospholipid antibody: laboratory, pathogenesis and clinical manifestations. Reumatismo. 62: 65-75
9. Alijotas-Reig, J., R. Ferrer-Oliveras, M. J. Rodrigo-Anoro, et al. 2010. Anti-beta(2)-glycoprotein-I and anti-phosphatidylserine antibodies in women with spontaneous pregnancy loss. Fertil. Steril. 93: 2330-2336
10. Cucnik, S., T. Kveder, Z. Ulcova-Gallova, et al. 2011. The avidity of anti-beta2-glycoprotein I antibodies in patients with or without antiphospholipid syndrome: a collaborative study in the frame of the European forum on antiphospholipid antibodies. Lupus. 20: 1166-1171
11. Zager, U., S. Irman, M. Lunder, et al. 2011. Immunochemical properties and pathological relevance of anti-beta(2)-glycoprotein I antibodies of different avidity. Int. Immunol. 23: 511-518
12. Cucnik, S., T. Kveder, I. Krizaj, et al. 2004. High avidity anti-beta 2-glycoprotein I antibodies in patients with antiphospholipid syndrome. Ann. Rheum. Dis. 63: 1478-1482
13. Cucnik, S., I. Krizaj, B. Rozman, et al. 2004. Concomitant isolation of protein C inhibitor and unnicked beta2-glycoprotein I. Clin. Chem. Lab. Med. 42: 171-174
14. Cucnik, S., A. Ambrozic, B. Bozic, et al. 2000. Anti-beta2-glycoprotein I ELISA: methodology, determination of cut-off values in 434 healthy Caucasians and evaluation of monoclonal antibodies as possible international standards. Clin. Chem. Lab. Med. 38: 777-783
15. Mayrose, I., O. Penn, E. Erez, et al. 2007. Pepitope: epitope mapping from affinity-selected peptides. Bioinformatics. 23: 3244-3246
16. Marai, I., A. Tincani, G. Balestrieri, and Y. Shoenfeld. 2005. Anticardiolipin and anti-beta-2-glycoprotein I antibodies. Autoimmunity. 38: 33-38
17. Ioannou, Y., C. Pericleous, I. Giles, et al. 2007. Binding of antiphospholipid antibodies to discontinuous epitopes on domain I of human beta(2)-glycoprotein I: mutation studies including residues R39 to R43. Arthritis Rheum. 56: 280-290
18. Inanc, M., E. L. Radway-Bright, and D. A. Isenberg. 1997. beta 2-Glycoprotein I and anti-beta 2-glycoprotein I antibodies: where are we now?. Br. J. Rheumatol. 36: 1247-1257
19. Ichikawa, K., A. Tsutsumi, T. Atsumi, et al. 1999. A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies. Arthritis Rheum. 42: 2461-2470
20. Castel, G., M. Chteoui, B. Heyd, and N. Tordo. 2011. Phage display of combinatorial peptide libraries: application to antiviral research. Molecules. 16: 3499-3518
21. Jurgec, I., M. Lunder, T. Bratkovic, et al. 2009. Hydrogen bonds are crucial for the anti-beta 2-glycoprotein I antibody bindings to the antigen. In European Workshop for Rheumatology Research. T.K. Kvien, ed. BMJ Publ. Group, Warsaw-Poland. p. A4
22. Giles, I., A. Lambrianides, and A. Rahman. 2008. Examining the non-linear relationship between monoclonal antiphospholipid antibody sequence, structure and function. Lupus. 17: 895-903
23. Blank, M., Y. Shoenfeld, S. Cabilly, et al. 1999. Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides. Proc. Natl. Acad. Sci. USA. 96: 5164-5168
24. Janeway, C
25. Lo, B K. Antibody Engineering: Methods and Protocols, 2004. Antibody Engineering: Methods and Protocols. Totowa, NJ: Humana Press. Totowa, NJ: Humana Press
26. Bottger, V 2001. Epitope Mapping with Random Peptide Libraries. Heidelberg: Springer Verlag
27. Agar, C., G. M. van Os, M. Morgelin, et al. 2010. Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome. Blood. 116: 1336-1343
28. Kasahara, H., E. Matsuura, K. Kaihara, et al. 2005. Antigenic structures recognized by anti-beta2-glycoprotein I auto-Antibodies. Int. Immunol. 17: 1533-1542
29. Lieberman, M
30. Elgert, K